U.S. Department of Labor Dictionary of Occupational Titles Call for Participation

We are writing to request your assistance with an important program sponsored by the U.S. Department of Labor (USDOL) known as the Occupational Information Network (O*NET). The USDOL is gathering occupational information in an effort to better define worker and work characteristics such as knowledge, skills, abilities, activities, and work context for nearly 900 occupational categories in the U.S. economy. As the data is collected and published, it will be used by millions of employers, workers, educators, and students (http://online.onetcenter.org). Much of the information already is in use by agencies and organizations across the nation (http://www.doleta.gov/programs/onet/oina.cfm).

The O*NET program is seeking experts in the occupations of Bioinformatics Scientist, Bioinformatics Technician, and Biostatistician.  The last complete update of the Dictionary of Occupational Titles was conducted by USDOL in the late 1970s. Basic criteria includes that data be provided by individuals who have performed the occupation for at least one year, have a five or more years of experience in the notedoccupation, andhave performed in that same arena duringthe past six months. This can bepracticing, consulting, teaching, instructing, supervising, etc. A short description of the occupation currently being updated is listed below. Please use the description, not the title, to decide if you may be a good match:

Bioinformatics Scientists:  Conduct research using bioinformatics theory and methods in areas such as pharmaceuticals, medical technology, biotechnology, computational biology, proteomics, computer information science, biology and medical informatics. May design databases and develop algorithms for processing and analyzing genomic information, or other biological information.

Bioinformatics Technicians:  Apply principles and methods of bioinformatics to assist scientists in areas such as pharmaceuticals, medical technology, biotechnology, computational biology, proteomics, computer information science, biology and medical informatics. Apply bioinformatics tools to visualize, analyze, manipulate or interpret molecular data. May build and maintain databases for processing and analyzing genomic or other biological information.

Biostatisticians:  Develop and apply biostatistical theory and methods to the study of life sciences.

The Bioinformatics Organization, Inc. is asking for volunteers from our membership to assist in the collection of information about these occupations.  Please be assured that your decision regarding participation in O*NET will not impact your standing as a member of the Bioinformatics Organization, Inc..

RTI International (RTI), a nonprofit research firm, is assisting USDOL with the O*NET data collection effort.  Please send an e-mail indicating your interest to participate, including your experience, title, last name, first name, address 1, address 2, City, State, ZIP code, day time Phone number, and Bioinformatics Scientist, Bioinformatics Technician, and Biostatistician area of specialty to Ron Wandscher, Business Liaison, at rwandscher@onet.rti.org.  You can also call 877-233-7348 ext. 108.

By participating, you will contribute to a key resource providing our nation with continuously updated occupational information.  Thank you in advance for your time and effort.

Council for Entrepreneurial Development’s Tech 2007 Conference – October 10-11, Chapel Hill, NC

The Conference will explore the future of emerging and converging technologies that are reshaping today’s hottest industries. Now in its 17th year, the Tech Conference will focus on the latest cutting-edge markets and global opportunities in clean technologies, gaming and digital media, medical devices, new materials, nanotechnology, telecom, internet, software and hardware and more. Attendees will be inspired by speakers and panelists including Najmi Jarwala, president of Sony Ericsson Mobile Communications USA; Edward Iacobucci, CEO of DayJet Corporation; and Don Dodge, director of Microsoft’s Emerging Technologies division and author of the blog, The Next Big Thing. Tech’s Demo Pavilion will serve as a launch-pad for over 35 innovative technologies from entrepreneurial companies, university groups, corporations and research institutions from across the Southeast and Mid-Atlantic. And, new this year, the hottest gaming technology companies will showcase their innovations at a special reception. Visit http://www.cednc.org/tech to learn more or call (919) 549-7500.

2nd Nano App Summit, Ritz Carlton, Cleveland, October 22 – 25, 2007

Nano App 2007 is the most applications focused nanotechnology event of the year, addressing industry-specific applications in Automotive, CleanTech and Defense sectors. You will hear major manufacturers, leading nanotechnology product developers, and industry experts share product enhancements, insight on current market demands, commercialization opportunities, and much more.  It’s all about nanotechnology applications today — not years into the future.

Open Innovator’s Toolkit

What advantages lead major corporations to look for their innovations outside the organization? How can you benefit from the revolutionary strategies of open innovation? Find out when you join your colleagues in technology acquisition and licensing at yet2.com’s ninth Executive Briefing, held this year in Boston at the Hyatt Harborside Hotel, November 4-6. Our topic is Accelerating Innovation: The Open Innovator’s Toolkit. As always, our speakers are thought-leaders, decision-makers, and practitioners who are doing it well. They’ll deliver specific suggestions to make your technology acquisition or licensing efforts even more successful. Recent conferences have averaged 140–150 leaders representing 100+ global corporations from Asia, Europe, and North America.

Call for Source Code for Biology and Medicine

Dear Colleague,

We would like to invite you to submit your next manuscript to Source Code for Biology and Medicine.

Source Code for Biology and Medicine is an open access, peer-reviewed online journal published by BioMed Central. It covers source code employed over a wide range of applications in biology and medicine. The journal is advised by an expert Editorial Board.

Thanks to Source Code for Biology and Medicine‘s open access policy, all articles published in the journal are freely accessible online. Articles published in Source Code for Biology and Medicine are highly visible and read by a wide audience. Two of the most accessed articles published in the journal since its launch are:

Accesses 4166

Software review
Gbrowse Moby: a Web-based browser for BioMoby Services
Mark Wilkinson
Source Code for Biology and Medicine 2006, 1:4 (24 October 2006)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
[Cited on BioMed Central]

Accesses 2028

Research
A traveling salesman approach for predicting protein functions
Olin Johnson, Jing Liu
Source Code for Biology and Medicine 2006, 1:3 (12 October 2006)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

To keep up to date with the latest articles, why not register to receive article alerts when new research is published?

Submit your research to Source Code for Biology and Medicine and take advantage of an efficient online submission process, a rapid, high quality peer-review service, and immediate publication upon acceptance. There are no color charges and no limits on the number of figures or embedded movies.

The published version of your article will be immediately placed in PubMed Central and other freely accessible full-text repositories. This complies with the NIH Public Access Policy and the Wellcome Trust Open Access Policy.

To enable the journal to make all of its content open access, Source Code for Biology and Medicine will levy an article-processing charge for each manuscript accepted after peer review (payable on acceptance).

Please submit your manuscript via our online submission system. For more information about the journal, contact peterson.leif@ieee.org or visit our instructions for authors.

Yours sincerely,

Emmanuel Ifeachor and Leif Peterson
Editors-in-Chief, Source Code for Biology and Medicine

Editors-in-Chief
Emmanuel Ifeachor (United Kingdom)
Leif Peterson (United States)

Editorial Board
Generoso Bevilacqua (Italy)
Elia Biganzoli (Italy)
Ramón Cacabelos (Spain)
Xue-wen Chen (United States)
Matthew Coleman (United States)
Anne Denton (United States)
Jose Fonseca (Portugal)
Paolo Frasconi (Italy)
Jonathan Garibaldi (United Kingdom)
Owen Hoffman (United States)
Jung-chang Huang (United States)
Vasily Leonov (Russian Federation)
Paulo Lisboa (United Kingdom)
Francesco Masulli (Italy)
Rita Noumeir (Canada)
Lucila Ohno-Machado (United States)
Silvano Paoli (Italy)
Giovanni Parmigiani (United States)
Ioannis Pitas (Greece)
Edward Sarkisyan-Grinbaum (Switzerland)
Scott Smith (United States)
Roberto Tagliaferri (Italy)
Manuel Ujaldon (Spain)
Staal Vinterbo (United States)
Michalis Zervakis (Greece)

CHI’s 3rd Annual Bridging Pharma and IT – Leveraging Information Technology to Improve Productivity

September 30 – October 2, 2007  |  Hyatt Haborside  |  Boston, MA

Bridging Pharma and IT Conference is the only multi-track meeting to feature case studies of IT/Science paired discussions that provide insights into cross-domain partnering with an organization’s end users and IT.

Keynote Presentations:

Doubling IT Innovation Spending: Laying the Foundation for IT-Enabled Business Process, Supply Chain, and Service Innovation in the Pharmaceutical Industry
Chris Asakiewicz, Ph.D., Affiliate Professor of Information Management, Stevens Institute of Technology, Wesley J. Howe School of Technology Management; former Vice President, Global Business Technology, Pfizer Global Pharmaceutical Division

Bridging Diagnostics Technologies with Pharma and Biotech
Tim Jaeger, Ph.D., M.B.A. Head of Medical and Scientific Affairs, Diagnostics Division, F Hoffmann La Roche AG

Creating the IT Infrastructure to Enable Adaptive Clinical Development
Jerald S. Schindler, Dr.P.H., Vice President, Late Stage Clinical Development Statistics, Merck & Co.

Lessons Learned: Challenges Faced in Sharing Information Across the Organization (Panel)
Marc Wine, MHA, Health Systems Analyst; Adjunct Professor Health Services Management and Leadership Department, The George Washington University   

Donald T. Mon, Ph.D., Vice President, Practice Leadership, American Health Information Management Association (AHIMA)

Mitchell Weisberg, Senior Principal, Hewlett Packard

6 Joint Case Studies From End Users & IT Executives

1.) Making the Most of Limited Resources: Creation of a Merckwide Biologics Database – Merck & Co., Inc.

2.) Developing a Knowledge Discovery Platform for Collaborative Research in Gastric Cancer – Singapore General Hospital & Nanyang Polytechnic

3.) Advancing Upload and Storage of Assay Data – Johnson & Johnson

4.) An Integrated Desktop Computing Environment for Chemists – Pfizer, Inc.

5.) IT Support for the Clinical Use of Genetics and Genomics – Could the Infrastructure in Place Today Be Strengthened through Collaborations with Pharma IT Departments? – Harvard Partners Center for Genetics & Genomics

6.) Are We Playing Dice With Informatics Projects? – Centocor R&D, Inc.

and More!!

Additional Presentations Include:

Developing of Enabling Informatics Technology in Support of the Development of Drug Candidates
Julie Hughes, Global Biologics Business IT Lead, Pfizer Global Research & Development

Building a Seamless Service – Implementing an SOA-Based Global Compound Sourcing Tool for Chemists
Mike Rippin, Ph.D., Director, Operations, Tessella, Inc.
Customer Co-Presenter TBD

One Company ~ 2 Worlds: Bridging Discovery and Development Information
Peter F. Thadeio, Research Porfolio Analyst, Pfizer Global R&D Groton Labs 

Using Biological Sequence Search to Validate Research Decisions
Kamalakar Gulukota, Ph.D., Senior Director, Content Development, GenomeQuest

Practical Applications of Modeling and Simulation in Clinical Studies
Dongzhou J. Liu, Ph.D., M.S., M.B.A., Principal Investigator, FRI New York

Application of Translational Informatics in Tailored Therapeutics
Susie Stephens, Ph.D., Research Scientist, Eli Lilly & Company

Brochure
Hotel
Register
Website

Howard R. Asher on the Convergence of IT and Life Sciences, Hypothetical Wireless Appliance

The Rady School of Management of the University of California, San Diego hosed the Second Annual Biotechnology Demystified Program to Teach the Science of Biotech to Business Professionals

Howard Asher, President and CEO of Global Life Sciences, Inc. presented on Technology Convergence: …the Role of IT in Life Sciences and Hypothetical Wireless Appliance.

Climate Savers Computing Initiative

<ed.note>In the meantime, of course, builders and computer vendors can begin deploying geothermal heat exchanger driven data centers. And we might all support the use of biosand water filters (portable potable) so there will actually be someone around to use those computers.</ed.note>

Believe it or not, the average desktop PC wastes nearly half the power delivered to it. Half! This wasted electricity unnecessarily increases the cost of powering a computer, and it also increases the emission of greenhouse gases. Improving the energy efficiency of computers is a cost-effective way to reduce electricity consumption and the emission of greenhouse gases that contribute to climate change. The Climate Savers Computing Initiative brings together industry, consumers and conservation organizations to significantly increase the energy efficiency of computers and servers.

Pharmaceutical Technology Annual Conference, July 24 – 26, 2007, Philadelphia, PA

FDA KEYNOTE ADDRESS:
FDA’s Pharmaceutical Quality Assessment in the 21st Century – A Modern Risk-Based Approach Moheb Nasr, Ph.D., Director, Office of New Drug Quality Assessment, CDER, FDA

Pharmaceutical Technology magazine, the premier leader in cutting-edge information for the pharmaceutical industry, presents a case study driven conference orchestrated by an advisory board of highly respected experts. With R&D costs reaching astronomical levels in recent years, no one from a research scientist in an analytical lab to a QA manager in a  manufacturing facility can afford to ignore the cost savings associated with achieving process excellence across the entire spectrum of drug development.

"It is almost like one stop shopping to anyone having to deal with Quality, become a Lean manufacturing machine,and look for new Technology that will help them get there…"

Jack R. Hoblitzell, Ph.D., Director, Formulations Development, Banner Pharmacaps

OPTIMIZE PROCESS EXCELLENCE:
– 30+ Case Studies and Presentations from FDA, Pfizer, Wyeth, Merck, AstraZeneca, Novartis, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, and more

– Lean Design and Development Applications on ALL levels from R&D through Manufacturing including Six Sigma, Validation, Formulation Development, Clinical Supply Manufacturing, Pharmaceutical Processes, and Manufacturing Product Lines

– Pharmaceutical Quality Initiatives Quality by Design (QbD), ICH Q8, ICH Q9, Quality Systems, Process Analytical Technology (PAT), Design of Experiments (DOE), and Risk Assessment

– Cutting Edge Technology PAT, Ultra Performance Liquid Chromatography (UPLC), ScanRDI, Laser Induced Breakdown Technology (LIBS), Data Automation, Mathematical Modeling, and Process Transfer

REGISTRATION:
Sign up today, and maximize the best price option for this conference.
Please visit or call toll free 1-888-524-9922 or 218-740-7028 (int’l only).

10% Off of Conference Registration For Bioinformatics.Org Members Only: Please use priority code BIODS when registering.

Download the Conference Agenda